A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
01/2003
01/02/2003	EP0883401B1 At1 receptor antagonist for the stimulation of apoptosis
01/02/2003	EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature
01/01/2003	CN1388757A Bioavailable dosage form of isotretinoin
01/01/2003	CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds
01/01/2003	CN1387911A Health wine for raising kidney function and immunity
01/01/2003	CN1387872A Nephropathy treating medicine and its prepn
01/01/2003	CN1387871A Chinese medicine shenkangwan bolus and its production process
01/01/2003	CN1387849A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack
01/01/2003	CN1387848A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack
01/01/2003	CN1097579C Ortho-substituted benzoylguanidines, process for their preparation, use and medicine containing them
12/2002
12/31/2002	US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases
12/31/2002	US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators
12/31/2002	US6500835 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
12/31/2002	US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/31/2002	US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists
12/31/2002	CA2227814C Substituted benzylaminopiperidine compounds
12/31/2002	CA2096532C New human recombinant gamma-interferon
12/27/2002	WO2002103042A2 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002	WO2002103027A1 Glycoprotein and process for producing the same
12/27/2002	WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/27/2002	WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	WO2002102771A1 Tryptase inhibitors
12/27/2002	WO2002102743A2 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
12/27/2002	WO2002102403A1 Mucosal repair by tff dimer peptides
12/27/2002	WO2002102399A2 Mucosal repair by tff2 peptides
12/27/2002	WO2002092565A3 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
12/27/2002	WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
12/27/2002	WO2002070473A3 Carboxamide derivatives as therapeutic agents
12/27/2002	WO2002055087B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
12/27/2002	WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002	WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
12/27/2002	CA2451638A1 Deuterated n-substituted and .alpha.-substituted diphenylalkoxy acetic acid amino alkyl esters and medicaments containing these compounds
12/27/2002	CA2450659A1 Tryptase inhibitors
12/27/2002	CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	CA2445731A1 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002	CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/26/2002	US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002	US20020198248 Therapeutic methods and compositions involving isoflavones
12/26/2002	US20020198235 Use of benzothiopenes to treat and prevent prostate cancer
12/26/2002	US20020198196 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
12/26/2002	US20020198191 Cyclohexylphenyl vasopressin agonists
12/26/2002	US20020198177 Coenzyme Q and EPA
12/26/2002	US20020198164 A toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence
12/26/2002	US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
12/26/2002	US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002	US20020198136 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc.
12/25/2002	CN1387539A Human monoclonal antibodies to prostate specific membrane antigen
12/25/2002	CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1387519A 2-imino-1,3-thiazine derivs.
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1387450A Use of dopamine-D3 receptor agonists for therapy of salt-dependent hypertension
12/25/2002	CN1387444A Method of treatment using anti-ErbB antibody-maytansinoid conjugates
12/25/2002	CN1387440A Methods for treating diabetes
12/25/2002	CN1387439A Treatment of diabetic nephropathy and microalbuminuria
12/25/2002	CN1386529A Medicine 'Shendantongling Keshi Dan' for treating renal calculus and biliary calculus
12/25/2002	CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/24/2002	US6498243 Epimorphin antagonist and process for producing it
12/24/2002	US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498142 Osteogenic protein-1 (op-1) and other members of the op-1 subfamily of the tgf-.beta. superfamily of growth factors
12/24/2002	US6497906 Anticholesterol, reduced menstrual bleeding
12/24/2002	CA2075878C Cyclic peptides and use thereof
12/21/2002	CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions
12/19/2002	WO2002101357A2 Molecular signatures of commonly fatal carcinomas
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100859A1 Pde iv inhibitors
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100819A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same
12/19/2002	WO2002100422A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/19/2002	WO2002100417A2 Use of glycosaminoglycans for the treatment of hiv-associated nephropathy
12/19/2002	WO2002100414A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
12/19/2002	WO2002100412A2 Stabilized dispersion of phytosterol in oil
12/19/2002	WO2002100402A1 Compositions comprising nitrofurantoin and uva ursi
12/19/2002	WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002080754A3 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002	WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002060421A3 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
12/19/2002	WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002	WO2002057222A3 Thiol-based naaladase inhibitors
12/19/2002	WO2002005795A3 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
12/19/2002	WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020193614 Treatment of cardiovascular disorders
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands
12/19/2002	US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein

1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 562